Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial

Condition(s) studied

Investigational drug(s) / intervention(s)

Death Conversation: On site, facilitator-led group discussion lasting 2 hours, covering: 1) Perceptions of death and dying. 2) Coping with death. 3) Readiness for Advance Care Planning (ACP)

Online ACP Education: An online asynchronous learning session with short videos on ACP with discussion forums.

Study summary

The goal of this clinical trial is to evaluate whether the Die-logue program can improve attitudes toward death, coping with death, and readiness for advance care planning (ACP) among community-dwelling middle-aged adults aged 40-60 years who have not completed any advance directives and not diagnosed with any life limiting diseases.

This study aims to address the following research questions:

* Does the Die-logue program improve community-dwelling middle-aged adults' attitudes towards death, ability to cope with death, readiness and uptake for Advanced Care Planning (ACP).
* What are community-dwelling middle-aged adults' perceptions of advance care planning, death and dying, and their experiences of participation in the Die-logue program.

Researchers will compare participants who receive the Die-logue program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve attitudes toward death, coping with death, and readiness for ACP.

Participants will:

* Complete online questionnaires measuring attitudes toward death, coping with death, and readiness for advance care planning.
* Participate in a facilitator-led group discussion session about perceptions of death, coping with death, and readiness for ACP (intervention group only).
* Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
* Complete follow-up surveys, including a 6-month follow-up assessing whether they have undertaken advance care planning.

Eligibility

Primary outcome measure(s)

• Death Attitudes — Before intervention
  Death Attitude Profile Revised Scale (DAP-R)
• Death Attitudes — Immediately after intervention
  Death Attitude Profile Revised Scale (DAP-R)

Trial sites (1)

More National University of Singapore trials in Singapore

Other trials for the same condition